These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 37724243)

  • 1. MicroRNAs in cardiovascular diseases.
    Li H; Zhan J; Chen C; Wang D
    Med Rev (2021); 2022 Apr; 2(2):140-168. PubMed ID: 37724243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular microRNAs in diabetic cardiomyopathy.
    Li H; Fan J; Chen C; Wang DW
    Ann Transl Med; 2020 Dec; 8(23):1602. PubMed ID: 33437801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
    Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
    Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
    Singh DD; Kim Y; Choi SA; Han I; Yadav DK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy in cardiovascular diseases: role of noncoding RNAs.
    Gao J; Chen X; Shan C; Wang Y; Li P; Shao K
    Mol Ther Nucleic Acids; 2021 Mar; 23():101-118. PubMed ID: 33335796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA therapeutics in cardiovascular diseases: promises and problems.
    Nouraee N; Mowla SJ
    Front Genet; 2015; 6():232. PubMed ID: 26175755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of noncoding RNAs in cardiac ageing.
    Varghese LN; Schwenke DO; Katare R
    Front Cardiovasc Med; 2023; 10():1142575. PubMed ID: 37034355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30 and 145 as Targets for the Treatment of Cardiovascular Diseases: Therapeutic Feasibility and Challenges.
    Tolouei SEL; Curi TZ; Klider LM; Junior AG
    Curr Pharm Des; 2021; 27(37):3858-3870. PubMed ID: 33308116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
    Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
    Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases.
    Li M; Duan L; Li Y; Liu B
    Life Sci; 2019 Sep; 233():116440. PubMed ID: 31047893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of pyroptosis in cardiovascular pathologies: Role of noncoding RNAs.
    Gao J; Chen X; Wei P; Wang Y; Li P; Shao K
    Mol Ther Nucleic Acids; 2021 Sep; 25():220-236. PubMed ID: 34458007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering Non-coding RNAs in Cardiovascular Health and Disease.
    Das A; Samidurai A; Salloum FN
    Front Cardiovasc Med; 2018; 5():73. PubMed ID: 30013975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases.
    Huang Y
    J Cell Mol Med; 2018 Dec; 22(12):5768-5775. PubMed ID: 30188595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microRNAs in cardiac hypertrophy and heart failure.
    Wang N; Zhou Z; Liao X; Zhang T
    IUBMB Life; 2009 Jun; 61(6):566-71. PubMed ID: 19472179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases.
    Kawaguchi S; Moukette B; Hayasaka T; Haskell AK; Mah J; Sepúlveda MN; Tang Y; Kim IM
    J Cardiovasc Dev Dis; 2023 Apr; 10(4):. PubMed ID: 37103045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology.
    Zhang YF; Xu HM; Yu F; Wang M; Li MY; Xu T; Gao YY; Wang JX; Li PF
    PPAR Res; 2018; 2018():8530371. PubMed ID: 30622558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ncRNAs and polyphenols: new therapeutic strategies for hypertension.
    Shirazi-Tehrani E; Chamasemani A; Firouzabadi N; Mousaei M
    RNA Biol; 2022; 19(1):575-587. PubMed ID: 35438046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases.
    Zhang C; Niu K; Lian P; Hu Y; Shuai Z; Gao S; Ge S; Xu T; Xiao Q; Chen Z
    Hypertension; 2021 Jul; 78(1):16-29. PubMed ID: 34058852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.
    Ultimo S; Zauli G; Martelli AM; Vitale M; McCubrey JA; Capitani S; Neri LM
    Oncotarget; 2018 Mar; 9(24):17238-17254. PubMed ID: 29682219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.